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This paper describes the results of a questionnaire survey on some aspects of nebulizer use, nebulizer 
instruction, and features relating to the recognition and management of deteriorating asthma. The study 
population consisted of 90 children with home nebulizers attending a paediatric asthma clinic, and 200 
asthmatic children and 200 asthmatic adults whose nebulizers had been purchased directly from a 
manufacturer in the U.K. The results suggest that follow-up supervision of the patients who bought their own 
nebulizers occurred in only approximately 25% of cases. Written information focusing on the management of 
symptoms was also lacking. Peak flow meters were being under-used. Although the majority (77-100%) of 
patients were aware of the ‘4 h rule’ for repeat use of bronchodilator therapy at home, there was still some 
confusion about the acceptable time interval and action to be taken should the dose be required more 
frequently. Very few (32%) in the nationwide adult group had a crisis action plan should the nebulizer fail to 
produce relief. This paper recommends that a simple treatment and crisis plan should be included with the 
purchased nebulizer, highlighting the key areas to be discussed by the patients with the doctor or other 
medical professionals. Such a package may prevent the occasional disaster that can occur with unsupervised 
nebulized bronchodilator usage. 
Introduction 
Asthma mortality and morbidity are unacceptably 
high. Many deaths and much unnecessary morbidity 
have been associated with over-reliance on bron- 
chodilators, inadequate medical supervision, under- 
use of inhaled and oral corticosteroid treatment, and 
a failure to make objective measurements of the 
severity of asthma (1). In studies on deaths from 
asthma involving retrospective analysis of action 
taken during an acute exacerbation (2-8) the most 
important, consistent theme in such deaths was sub- 
optimal management of the final attack due to an 
inability to recognize the severity of the attack and a 
delay in seeking medical help. 
An increasing number of people with chest prob- 
lems are using home nebulizer therapy. Opinion is 
divided on the safety of such widespread use (9) and 
there are anecdotal instances of misuse of this 
therapy (9). Some studies have suggested that more 
widespread home nebulization could reduce mortal- 
ity (2,lO). An opposing view is that patients may 
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place excessive confidence in a piece of equipment 
which appears to be ‘technical’, as distinct from the 
less visually dramatic inhalers. Grant (3)’ suggested 
that nebulizers could result in people over-relying on 
their bronchodilators and failing to call for further 
medical assistance; this might lead to death. 
The suggestions of many authors (2-8, 10-13) on 
nebulizer use are reinforced by the British Thoracic 
Society (BTS) Asthma Guidelines (14) which advo- 
cate greater participation of the parent or patient 
in the management of asthma. The BTS guide- 
lines for supervision of people receiving nebulized 
bronchodilators at home state: 
1. Oral and written instruction should be given to 
the patient on the method and frequency of use, the 
action to be taken in the event of worsening asthma, 
and when to attend for follow-up. 
2. Supervision should normally entail attendance 
at an asthma clinic or home visits by a trained asthma 
nurse or physiotherapist. 
3. Supervision should include evaluation of peak 
expiratory flow, monitoring of prescriptions, and 
twice yearly servicing of the compressor. 
Within the country, many asthma specialists 
now operate effective systems for loaning patients 
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nebulizer units, giving accompanying education 
packages. However, it is likely that some people 
purchasing their own nebulizers do not become 
involved in such a support scheme. This study com- 
prises two parts. Firstly, it audits the Southampton 
General Hospital Paediatric Asthma Clinic nebulizer 
instruction package which contains practical demon- 
stration and written information on nebulizer use 
and the recognition and management of deteriorating 
asthma. Secondly, it comprises a comparison 
between two populations of nebulizer users on the 
level of supervision and instruction on nebulizer use 
for worsening asthma which they feel they received. 
The two populations were drawn from across the 
U.K. and had purchased their machines directly from 
a manufacturer?. 
Methods 
The survey took the form of a postal question- 
naire. The study population was grouped as follows. 
HOSPITAL AUDIT 
Ninety children with home nebulizers attending 
Southampton General Hospital Paediatric Asthma 
Clinic (76 units on loan and 14 privately purchased). 
This group was designated SGHchild; ‘SGHC’. 
NATIONAL SAMPLES 
Two hundred asthmatic children whose parents 
had purchased their nebulizers directly from the 
manufacturers. This group was designated United 
Kingdom-child; ‘UKC’. 
Two hundred asthmatic adults who had purchased 
their nebulizers directly from the manufacturers. This 
group was designated United Kingdom-adult; 
‘UKA’. 
Names and addresses for the two national samples 
were obtained from the purchase records of the 
manufacturer ‘Medic Aid Ltd’; all those contacted 
were believed to have asthma. The questionnaire was 
produced in two formats; one directed to adult 
purchasers with asthma, the other for parents of 
children with asthma (16 years of age and younger). 
Non-responders were sent one further copy of the 
questionnaire. Question style was initially piloted on 
SGH paediatric patients with loaned nebulizers who 
had respiratory disorders other than asthma (e.g. 
cystic fibrosis). Medical jargon was avoided. Subjects 
were asked to state their diagnosis; those found not 
to have asthma had question responses coded as 
‘not applicable’ for questions relating to asthma 
tMedic Aid Limited, Chichester, U.K. 
management. All responses given by the subjects 
reflect the information they feel they received. 
Unfortunately, it was not possible to discover what 
information their doctor felt they had been given. 
The majority of the questions were multiple choice 
format, with room for additional comments where 
appropriate. People’s responses to an acute attack 
were assessed using a series of scenarios, with ques- 
tions on appropriate responses. Two open questions 
were used to discover how the patient’s respiration 
and appearance would change during an exacerba- 
tion. The answers were then interpreted by the 
investigator to identify seven important factors, with 
an eighth section for other relevant features. 
Data processing was performed using SPSS4. The 
chi-squared test was used to compare the groups; a 
probability value of less than 0.05 was considered 
significant. Where tables contained small numbers, 
Fisher’s Exact Test was used, calculating l-tailed P 
values which were then doubled. 
Approval for the trial was granted by 
Southampton Joint Ethics Committee. 
Results 
HOSPITAL AUDIT (TABLES I AND 2) 
There was a response rate of 77% (69) amongst the 
SGH children’s families. Of these, 99% had received 
initial instruction on nebulizer use, were satisfied with 
the information package supplied and felt confident 
about using their nebulizers. A peak flow meter was 
used at home by 80% of 5 and 6 year olds and 86% of 
the older children to monitor their condition. Cyano- 
sis, wheeze/cough, laboured breathing and increased 
respiratory rate were identified by 57-88% of families 
as possible identifying features of an acute respira- 
tory attack, 54% mentioning four or more features 
of respiratory distress. They were all aware of the 
‘4 h rule’ which states that unsupervised repetition 
of bronchodilators is once every 4 h while more 
frequent usage should lead one to seek medical 
assistance and take oral steroids. Should the nebu- 
lizer fail to produce relief, 99% possessed a crisis 
plan; 2% of whom would immediately commence 
oral steroids, the rest stating they would seek medical 
assistance with or without commencing oral steroids. 
NATIONAL GROUPS - COMPARISON BETWEEN ADULTS 
AND CHILDREN 
One hundred and twelve children’s families (56%) 
replied to the questionnaire, 95% had childhood 
asthma and one child had cystic fibrosis. The major- 
ity of children (70%) using nebulizers were aged 
below 5 years, the other 30% equally divided between 
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Table I Details of instruction received concerning nebulizer use 
UKC 
n=112 
Instruction details VQ) 
UKA SGHC 
n=l16 n=69 
(“/I WI 
Patient received initial instruction 
From Doctor 
Nurse 
Physiotherapist 
Satisfied with initial instruction 
Received follow-up supervision 
Confidence in using nebulizer 
Confident 
Fairly confident 
Fairly unconfident 
Unconfident 
Patient considered nebulizer could lead to poor 
treatment of an attack 
92 98 99 
37 56 16 
49 25 6 
5 13 88 
87 86 99 
27 23 94 
77 55 99 
23 38 1 
0 5 0 
0 2 0 
61 21 67 
UKC, United Kingdom children population - nationwide sample; UKA, United Kingdom 
adult population - nationwide sample; SGHC, Southampton General Hospital children 
population. 
children aged 5 or 6 years, and children older than 
6 years. Responses were received from 116 adults 
(58%); 67% had asthma and 28% had chronic 
obstructive airways disease. Pattern of care varied in 
that more adults (55%) than children (33%) were 
treated in the community alone, while most children 
had care shared between their GP and hospital (47% 
children and 39% adults). The remaining 20% of 
children and 4% of adults were managed by their 
hospital. 
Table 1 gives details of instruction which the 
patients felt they received about their nebulizer. Most 
patients had some form of initial instruction; mainly 
from a doctor, nurse or physiotherapist. Only 
approximately one-quarter received follow-up super- 
vision. The form which initial instruction took varied 
considerably. The majority of respondents were sat- 
isfied with their initial instruction. Some dissatisfied 
people commented that they wanted someone local to 
whom they could refer in times of difficulty. Others 
requested written information. Interestingly, most 
people felt confident about using their nebulizer - 
this confidence perhaps not always being appropriate 
in relation to their medical knowledge. When asked 
whether the patient felt a nebulizer could in any way 
lead to poor treatment of an attack, children seemed 
more alert to this than adults. Of those who felt it 
could, the majority stated over-reliance or over- 
under-dose as their concern. One person mentioned 
the temptation of not ‘bothering’ with prophylaxis. 
The following three areas relating to asthma ex- 
acerbations were examined: the patient’s ability to 
recognize a severe respiratory attack, their knowl- 
edge of appropriate instruction for treating such an 
attack and to ascertain whether they had a crisis 
plan to follow should the nebulizer fail to produce 
relief. 
Ability to recognize a severe respiratory attack 
(Table 2) 
Only 33% of adult patients stated that they pos- 
sessed a peak flow meter and would use it to assess 
their tightness. The number of children using a flow 
meter varied with age. Significantly more of the 
children aged over 7 years used meters when com- 
pared with the adults (P<O.OOl). All those who had a 
meter at home understood what it was for; 5% who 
did not have a home meter also knew its purpose. 
Scoring of the open questions asking participants 
to describe how their appearance and behaviour 
would alter during an attack revealed that the parents 
reported relatively frequently on physical signs listed 
in the table, while the adults did not, except for 
‘laboured’ breathing and less specific features 
(‘other’). 
Knowledge of appropriate instruction for treating an 
acute attack (Table 2) 
All respondents were prescribed nebulized bron- 
chodilator therapy. The majority of both groups 
understood the ‘4 h rule’ for safe maximal repetition 
of bronchodilator therapy at home (34 hourly in 
some cases). However, the parents of one of the UKC 
population was happy to give it hourly. 
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Table 2 Factors influential in a patient’s ability to manage an acute exacerbation of asthma 
(*P<O.OOl for UKA & UKC) 
Key factors 
UKC UKA SGHC 
n=107 n=77 n=69 
(“/I WI W) 
Home use of PEFR meter 
<5 years old 
5 and 6 years old 
7-16 years old 
Adult 
10 9 
18 80 
69 86 
*33 
Mention of factors identifying acute respiratory distress 
(1) Altered breathing 
Wheeze/cough 
Increased respiratory rate 
Hyperinflation/recession 
Laboured breathing 
(2) Altered behaviour and appearance 
Cyanosis/paler 
Difficulty speaking/eating 
Inability to walk/play 
Other 
% Mentioning four or more features 
Safe repetition of bronchodilators 
4 hourly 
~3 hourly 
>8 hourly 
Did not know 
Action if exceed safe frequency of bronchodilators 
Seek medical assistance & steroids 
Repeat medicine only or oral steroids only 
Relaxation only 
Additional metered dose inhaler only 
No further action 
Possession of crisis plan if nebulizer fails to relieve 
% With plan 
Action 
71 33 60 
59 36 88 
32 3 32 
67 75 74 
39 2 57 
21 11 35 
36 8 36 
78 57 91 
36 *3 54 
81 77 100 
13 7 0 
0 8 0 
6 7 0 
97 *64 100 
1 5 0 
2 4 0 
0 *18 0 
0 *9 
73 31 99 
70 *2ci 97 
3 2 2 
0 1 0 
0 2 0 
UKC, United Kingdom children population - nationwide sample; UKA, United Kingdom 
adult population - nationwide sample; SGHC, Southampton General Hospital children 
population, *P<O.OOl for UKA and UKC. 
Seek medical assistance f steroids 
Oral steroids only 
Repeat medicine only 
Use metered dose inhaler only 
Most of the study population said they would seek nebulizer, only 31% of the adults compared with 73% 
medical assistance if exceeding the safe nebulized of the U.K. children had such a plan. The table 
bronchodilator frequency. However, 18% of the indicates that most people with a plan would seek 
UKA population (one-quarter of the adults under medical assistance, but 5% of adults would not seek 
the care of thei,r GP only) would solely take addi- medical assistance, this difference being statistically 
tional doses of their bronchodilator metered dose significant from the paediatric group (P<O.OOl). 
inhaler. An alarming 9% of the UKA population 
would take no further action. 
Discussion 
Crisis plan ifnebulizer fails to produce relief (Table 2) The need for patient education and supervision 
When asked whether people had a contingency concerning home nebulization has been stressed 
plan should they fail to derive benefit from the (1,12,13), yet this survey reinforces the idea that such 
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Action Plan for 
Worsening Asthma 
Use peak flow meter 
Take usual dose of reliever medicine 
. . . . . . . . . . . . . . . . . . . (name) 
\Yes 
I  I  
Give further 
treatment 
as required 
\1 / 
I Treatment needed sooner than 4 h later? / 
, No 
I Repeat as required. If needed for longer than 24 h CALL DOCTOR! 
Fig. 1 Action plan to be included when a nebulizer is 
purchased. 
follow-up monitoring and reinforcement may be 
lacking. Amongst the patients who purchased their 
own units, there was a very poor level of follow-up 
supervision. Only 25% had follow-up supervision. 
Clear instruction on use of the nebulizer is pro- 
duced by the manufacture& which states the units: 
‘should only be used by prescription or under the 
direction of a doctor’ and medical instruction should 
be sought on how to take the nebulizer treatment. 
These statements are further echoed in the BTS 
guidelines (14) and National Asthma Campaign 
booklet (15) on nebulizer use which includes basic 
guidelines for home nebulizer use. The booklet states 
that further information must be gleaned from medi- 
cal personnel who should write down instructions on 
treatment and action plans for worsening asthma 
symptoms. Bendefy (16) states that written as well as 
verbal instructions are essential for safe home nebu- 
lization. The recently published GRASSIC study (17) 
found that patients valued most highly the sections of 
their educational booklets that gave objective advice 
about the action to be taken when patients felt 
breathless, the most popular topic being ‘what to do 
in a severe asthma attack’. Again, it appears that 
education about asthma in general may not be of 
$Medic Aid Limited, Chichester, U.K. 
great benefit; what is effective is information focusing 
on the management of symptoms. Responses in this 
study suggest that our hospital group has derived 
benefit from their package of written and verbal 
information. However, it is likely that the 21 non- 
responders to the questionnaire have poorer knowl- 
edge than the 69 who replied. A crisis plan was not 
felt to have been provided for one-quarter of the 
UKC population and two-thirds of the UKA popu- 
lation. In view of this finding, in addition to the 
practical information issued by manufacturers, each 
nebulizer purchased should include a medical card 
containing a table for treatment plans, signs of 
respiratory distress and action plan (Fig. 1) to be 
deleted and completed appropriately for the patient. 
Controlled, prospective evaluation of the effective- 
ness of such a card, both in terms of affecting 
perceived knowledge and actual action in a crisis, 
should be undertaken. 
In the two national groups, the relatively high level 
of satisfaction with initial instruction received and 
general high level of confidence concerning nebulizer 
use is not borne out by the responses to medical 
questions. Perhaps patients are satisfied with know- 
ing how, rather than knowing when, to deliver nebu- 
lized therapy. A clinical impression is that because 
one can see and hear them working and because 
larger doses of treatment are administered in nebu- 
lizers, they are often viewed by patients as panaceas, 
and may instill the patient with a false sense of 
security. The variety of reasons why people purchase 
nebulizers range from an attempt to avoid occasional 
hospital admissions, to facilitation of administration 
of regular therapy. The purpose of this paper is not 
to assess the appropriateness of this form of treat- 
ment delivery. Nevertheless, all who have one must 
be instructed to respond appropriately in the event of 
an emergency. 
Subjective assessment is said to be a poor indicator 
of airway obstruction (18). Recent work suggests that 
60% of patients with asthma are poor discriminators 
of asthma (19). It is therefore essential that simple 
peak flow meter recording is used for home monitor- 
ing. In children, educational efforts involving concise 
management plans (20) can influence the self- 
management behaviour of parents, and many parents 
find home peak flow monitoring helpful in recogniz- 
ing severe asthma attacks (21). The small number of 
adults (33%) using meters is alarming, but concurs 
with the national audit of asthma attacks in Britain in 
1991-1992, which found that only 29% of patients 
had their own peak flow meter (22). 
Fletcher (7) and Buranakul (8) stated that parents 
must be educated to recognize the danger signs of 
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severe respiratory distress. Parents more frequently 
recognized such signs than the adult patients. It is 
obviously harder for the adult sufferers to be aware 
of changes occurring in themselves, compared with 
parents who are observing their child. This again 
emphasizes the need for peak flow meter monitoring. 
A useful criterion for hospital admission is failure 
to respond to two doses of bronchodilators adminis- 
tered 4 h apart (23). Failure to respond or poor 
response to the usual dose of inhaled p-agonist is 
probably the most important symptom of deteriora- 
tion and indicates the need for immediate assessment 
and change of therapy (1,8,24,25). The majority of 
both groups stated they would use bronchodilators 
4 h apart, but one-fifth of the U.K. population is a 
worrying proportion to be unaware of this rule. It is 
interesting to note that children with asthma whose 
parents had bought a nebulizer were more likely to be 
seen by a Consultant Paediatrician, to be given a 
peak flow meter and appropriate advice on the use of 
their nebulizer than adults. 
It has been stated (2-7,10,11) that possession of 
nebulizers has led to doctors overlooking the 
subject’s requirement for further intervention such as 
oral steroids. Some comments in the survey reinforce 
this idea; ‘Doctors feel you have the same amount of 
treatment available as the GP’ ‘Ambulancemen, 
particularly non-paramedics seem to think all has 
been done and that I’ll get over it on my own when 
they see the nebulizer’. Oral steroids have been 
described as ‘accepted practice’ in management of 
adult asthmatics but some paediatricians have been 
reluctant to apply this to children (11). A relatively 
small number of people in any category of our survey 
commented on use of home oral steroids. Although 
early commencement is essential, their prescription 
must be judicious and accompanied by written 
instruction. 
This survey must confine itself to assessing the 
appropriateness of knowledge that responders believe 
they have received concerning nebulizer use; it cannot 
comment on the actual behaviour of participants in 
times of crisis. Nor should the findings of these 
nebulizer owners be applied to all home users, many 
of whom one hopes will be involved in specialist 
asthma loan support schemes. In general, we believe 
that if a patient is considered to need a home 
nebulizer then they should be supervised by a clinic 
capable not only of providing appropriate education 
and training, but also a regular maintenance service. 
Nebulizers should be serviced twice yearly (14). How- 
ever, concerns about inadequate education on home 
nebulizer use are still justified today. It is unwise to 
assume that the medical aspect of home therapy can 
be directed and assessed by all doctors (26), yet many 
doctors are put in the position of being the only 
source of information for the patient. Nor is it 
correct to assume that people know how to use a 
nebulizer safely. Inclusion of a card (Fig. 1) which 
could be located in the nebulizer casing of all manu- 
factured nebulizers would place the onus on each 
nebulizer purchaser to ensure that it is completed by 
the doctor or asthma specialist and would raise 
questions in the purchaser’s mind on the information 
he needs to absorb. Used sensibly, nebulizers may 
play a vital role in reducing asthma morbidity and 
hospital admissions. 
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